Kris Verburgh is a medical doctor, researcher, investor, and author with deep expertise in aging, longevity, and biotechnology. He currently serves as General Partner & Head of Science at BOLD Longevity Growth Fund, where he focuses on investing in advanced biotechnologies aimed at slowing down aging. Prior to this, Verburgh was Partner and Head of Science at Longevity Vision Fund, a $100 million fund that also invested in longevity biotechnologies.